This course will present a high level overview of the “other” MRI methods (dT1, DSC, BOLD, ASL, MRS) that have been used for the assessment of cancer, with a focus on their utility in brain tumors. The specific emphasis will be on quantification, which is becoming increasingly necessary to detect and track changes over time with the goal of optimal response assessment.
This abstract and the presentation materials are available to members only; a login is required.